Methods and compositions utilizing quinazolinones
US6545004B1 · kind B1 · utility
75Cited by
54References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2000 |
| Grant date | Apr 8, 2003 |
| Priority date | — |
| Expiry date | Oct 24, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/91
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.